Interim tissue rule
This article was originally published in The Gray Sheet
Executive Summary
FDA issues final rule amending regs for human cells, tissues, and cellular and tissue-based products. Changes relate to oocyte and embryo donation screening and testing procedures. The modifications were effective May 25, concurrent with FDA's tissue reg implementation (1"The Gray Sheet" Nov. 22, 2004, p. 6). Comments are due Aug. 23...